Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly received approval for a plant development in Pennsylvania and paid a milestone payment to Nxera Pharma.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pennsylvania
state of the United States of America
-
Eli Lilly and Company
American pharmaceutical company
-
Nxera Pharma
company in Tokyo, Japan
Nothing else this week.
Related events
- Agreement between Eli Lilly and Hims & Hers Health expands access to Lilly's medicines.
- Eli Lilly and Company received full FDA approval, expanded a safety study into India, and broke ground on a new facility in Houston while competing in the GLP-1 market.
- Eli Lilly is building a new facility in Pennsylvania, with Governor Shapiro attending the groundbreaking ceremony.